TY - JOUR
T1 - A comparison of postoperative radiotherapy with postoperative chemotherapy in stage II-IV ovarian cancer patients
AU - Menczer, J.
AU - Ben-Baruch, G.
AU - Modan, M.
AU - Brenner, J.
AU - Brenner, H.
PY - 1984/2
Y1 - 1984/2
N2 - A retrospective comparison between 28 stage II-IV ovarian cancer patients who received postoperative abdominopelvic irradiation and 15 such patients who received postoperative cis-platinum, Adriamicin, and Cytoxan chemotherapy was made. In both treatment groups there was a trend for a longer progression-free interval and 3-year survival in patients with residual tumor masses of less than 2 cm in diameter. In these patients there was also a trend favoring radiotherapy. However, all differences were not significant. Criteria for the choice of either modality of postoperative therapy of ovarian cancer patients remain to be determined. Nevertheless, the efficacy of both modes of treatment does not differ greatly.
AB - A retrospective comparison between 28 stage II-IV ovarian cancer patients who received postoperative abdominopelvic irradiation and 15 such patients who received postoperative cis-platinum, Adriamicin, and Cytoxan chemotherapy was made. In both treatment groups there was a trend for a longer progression-free interval and 3-year survival in patients with residual tumor masses of less than 2 cm in diameter. In these patients there was also a trend favoring radiotherapy. However, all differences were not significant. Criteria for the choice of either modality of postoperative therapy of ovarian cancer patients remain to be determined. Nevertheless, the efficacy of both modes of treatment does not differ greatly.
UR - http://www.scopus.com/inward/record.url?scp=0021327646&partnerID=8YFLogxK
U2 - 10.1016/0090-8258(84)90079-9
DO - 10.1016/0090-8258(84)90079-9
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0021327646
SN - 0090-8258
VL - 17
SP - 207
EP - 212
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 2
ER -
